Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that MK-3120 is being evaluated for safety and efficacy in participants with advanced solid tumors in a Phase 1/2 study, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm
• Solid Tumors

Drugs mentioned

• MK-3120

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Advanced Solid Tumors, Malignant Neoplasm | Phase 1, Phase 2 | Status: RECRUITING